{"nct_id":"NCT03110380","title":"Switching to a Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Adults Who Are Virologically Suppressed","status":"COMPLETED","status_verified_date":"2021-12","start_date":"2017-06-12","start_date_type":"ACTUAL","primary_completion_date":"2018-12-04","primary_completion_date_type":"ACTUAL","completion_date":"2021-02-10","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GILD"]}